Related Experiment Video
Updated: Mar 8, 2026

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
[Cytomegalovirus disease in post-heart-transplant patients at a national reference center]
Christian Rojas-Contreras1, Gabriel De la Cruz-Ku2, Bryan Valcarcel-Valdivia2
1Servicio de Infectología, Instituto Nacional Cardiovascular, Lima, Perú.
Insights
Cytomegalovirus disease affects 5.7% of heart transplant recipients, often occurring despite prophylaxis. Prompt diagnosis and treatment are crucial for remission in these patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Transplantation Medicine
Background:
- Heart transplantation is the primary treatment for end-stage heart failure.
- Cytomegalovirus (CMV) disease is a significant post-transplant infectious complication.
Purpose of the Study:
- To determine the prevalence of cytomegalovirus disease post-heart transplant.
- To describe the clinical features of cytomegalovirus disease in heart transplant recipients.
Main Methods:
- Retrospective descriptive study of 35 heart transplant patients (2010-2015).
- Data collected via medical record review.
- Analysis of demographic and clinical variables for CMV disease cases.
Main Results:
- Prevalence of cytomegalovirus disease was 5.7% (2 patients).
- Both affected patients were cytomegalovirus-seronegative pre-transplant.
- CMV disease occurred both during and after valganciclovir prophylaxis.
Conclusions:
- The prevalence of CMV disease in this cohort is lower than reported in other studies.
- Cytomegalovirus disease can be successfully treated with timely diagnosis and appropriate medical management.
Introduction:
Heart transplantation remains as the treatment of choice when the heart failure is refractory to the medical or surgical therapy. Therefore, cytomegalovirus disease is an important post-heart-transplant infectious complication.
Aims:
To describe the prevalence and clinical characteristics of the cytomegalovirus disease after heart transplant surgery.
Materials And Methods:
A retrospective, descriptive study was conducted. It enrolled 35 heart-transplant patients attended in the Cardiovascular National Institute (INCOR), between 2010 and 2015. The information was obtained through the review of medical records. The demographic and relevant clinical variables were analyzed for the cytomegalovirus disease cases.
Results:
The population mean age was 39.49 ± 15.07 years and most of them were male patients (63%). The prevalence of the cytomegalovirus disease was 5.7% (two patients), both were seronegative for cytomegalovirus before transplantation. One of the patients had the disease before finishing the valganciclovir prophylaxis and the other after the end of it.
Conclusion:
The prevalence of the cytomegalovirus disease is slightly lower than in other studies. Moreover, the cytomegalovirus disease can remit with a prompt diagnosis and the proper medical treatment.
More Related Videos
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
11:18Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Related Concept Videos
Kidney Transplant I: Introduction
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Kidney Transplant III: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies